START-UP’s 2013 Life Science Venture Capital Survey: Lights, Even Exits, At The End Of A Dark Tunnel

Article preview from Start-Up - September, 2013

Our third annual survey of institutional and corporate VCs arrives as life science investing reaches a crossroads. Public markets are gung ho for new biotech companies, lifting the spirits of a subset of our respondents, but VCs still face big hurdles to raise new funds.

START-UP’s 2013 Life Science Venture Capital Survey: Lights, Even Exits, At The End Of A Dark Tunnel

Article preview from Start-Up - September, 2013

In 2013, the life science venture industry is recovering. That much is clear. Is the recovery part of a classic cycle that will bring big money and big crowds back to the sector? Or have the fiscal doldrums of the past half-decade fundamentally altered the way investors help build life science companies, with biopharma turning to new financing models and corporate venture partners, and with device VCs facing a scarcity of capital? In this, our third annual START-UP Life Science Venture Capital Survey, we’re on the cusp of answering those important questions, but we don’t have a conclusive answer.

We are seeing market demand for venture-backed companies, but VCs still expect their own ranks to keep shrinking in coming years. Still, a brightening mood is an inescapable headline this year. On the whole, life science VCs are feeling better than they have for several years, fueled in part by public market clamor and corporate investment largesse.

Continued...

To read this article in its entirety, purchase now, as a PDF and recieve it immediately via email. Or get it free when you subscribe to Start-Up.

About Start-Up

No publication reviews leading edge companies and technology better than Start-Up. Each issue of Start-Up profiles the most important new product companies, identifies the hottest technology areas, reviews funds flowing into private companies and investment trends, and reports on university tech transfer licensing. Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics.

Plus:
To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985-9512